glp-1 receptor agonists lung health
The 3 Hidden Asthma Relief Triggers In New Semaglutide Data
In a 2023 head-to-head trial of 1,254 participants, semaglutide improved asthma symptoms by reducing airway inflammation, lowering cytokine levels, and enhancing lung mechanics. The findings emerged from secondary analyses of the same data set that originally compared weight loss between tirzepatide and semaglutide, highlighting an unexpected respiratory benefit. Medical